Relmada Therapeutics Inc.

0.27
-0.02 (-5.59%)
At close: Apr 11, 2025, 9:35 AM

Relmada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017
-79.98M -98.79M -157.04M -125.75M -59.46M -15.01K -17.32M -8.96M -6.29M
n/a n/a n/a 1.26K 3.75K 4.36 4.87K 2.63K 85.27K
30.19M 43.81M 44.19M 40.49M 20.78M 2.76K 1.21M 518K 704.45K
-1.58M 4.32M 10.17M -10.71M 3.03M -26.46 1.35M 542.67K 482.46K
-381.66K 241.31K -1.55M 1.25M 16.95K 172.81 266.76K 1.03M -721.84K
n/a n/a n/a n/a n/a n/a 3.83M 708.9K -620.25K
-1.58M 3.08M 10.59M -7.86M 10.85M -26.46 1.51M 700.06K -247.69K
-51.76M -51.66M -103.8M -91.87M -27.81M -12.09K -10.5M -6M -6.47M
n/a n/a n/a n/a n/a n/a n/a -12.39K -49.69K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a -90.46M -47.29M -222.98M -182.05M n/a n/a n/a n/a
n/a 140.92M 67.03M 168.86M 147.6M n/a n/a n/a n/a
51.56M n/a 19.73K -54.12K -34.45K -80.16K n/a n/a n/a
51.56M 50.45M 19.73M -54.12M -34.45M -80.16K n/a -12.39K -49.69K
n/a n/a n/a n/a n/a n/a -285.17K 6.54M -273.67K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-40.34K -98.46K 2.29M 2.63M 28.47M 126.11K n/a n/a n/a
-40.34K -98.46K 45.02M 187.94M 28.47M 126.11K 17.48M 6.54M -273.67K
-234.54K -1.3M -39.05M 41.95M -33.78M 6.98K 6.98M 528.43K -6.79M
-51.76M -51.66M -103.8M -91.87M -27.81M -12.09K -10.5M -6.01M -6.52M